CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
17 hedge funds and large institutions have $5.13M invested in Cellular Biomedicine Group, Inc. in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$27K | |
| 2 | +$25K | |
| 3 | +$9.75K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.11K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$721 |
Top Sellers
| 1 | -$640K | |
| 2 | -$225K | |
| 3 | -$156K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$38K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$18.7K |